FDA
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Announces Publication of Long-Term Efficacy and Safety Data Supporting FYARRO
-
-
-
-
-
-
-
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
-
-
-
-
-
-
-
Aadi Bioscience to Participate in Upcoming Investor Events
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Appoints Mohammad Hirmand to its Board
-
-
-
-
-
-
-
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference
-
-
-
-
-
-
-
Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium
-
251,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All